Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma

ROBNETT, Theodore J ; MACHTAY, Mitchell ; STEVENSON, James P ; ALGAZY, Kenneth M ; HAHN, Stephen M

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Phase I Clinical/Pharmacokinetic and Pharmacodynamic Trial of the c-raf-1 Antisense Oligonucleotide ISIS 5132 (CGP 69846A)

STEVENSON, J. P ; YAO, K.-S ; DORR, F. A ; O'DWYER, P. J ; GALLAGHER, M ; FRIEDLAND, D ; MITCHELL, E. P ; CASSELLA, A ; MONIA, B ; KWOH, T. J ; YU, R ; HOLMLUND, J

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer

Petty, Russell D ; Dahle-Smith, Asa ; Stevenson, David A J ; Osborne, Aileen ; Massie, Doreen ; Clark, Caroline ; Murray, Graeme I ; Dutton, Susan J ; Roberts, Corran ; Chong, Irene Y ; Mansoor, Wasat ; Thompson, Joyce ; Harrison, Mark ; Chatterjee, Anirban ; Falk, Stephen J ; Elyan, Sean ; Garcia-Alonso, Angel ; Fyfe, David Walter ; Wadsley, Jonathan ; Chau, Ian ; Ferry, David R ; Miedzybrodzka, Zosia

United States

Texto completo disponível

Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer

STEVENSON, James P ; REDLINGER, Maryann ; KLUIJTMANS, Leo A. J ; WEIJING SUN ; ALGAZY, Kenneth ; GIANTONIO, Bruce ; HALLER, Daniel G ; HARDY, Christine ; WHITEHEAD, Alexander S ; O'DWYER, Peter J

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Mechanisms of Hypertension Associated With BAY 43-9006

VERONESE, Maria Luisa ; MOSENKIS, Ari ; FLAHERTY, Keith T ; GALLAGHER, Maryann ; STEVENSON, James P ; TOWNSEND, Raymond R ; O'DWYER, Peter J

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow

STEVENSON, James P ; ROSEN, Mark ; CHAPLIN, David ; YOUNG, Scott L ; SCHNALL, Mitchell ; O'DWYER, Peter J ; WEIJING SUN ; GALLAGHER, Maryann ; HAILER, Daniel G ; VAUGHN, David ; GIANTONIO, Bruce ; ZIMMER, Ross ; PETROS, William P ; STRATFORD, Michael

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Phase II study of bevacizumab and erlotinib in treatment-naive elderly patients (older than age 65) with advanced non-small cell lung cancer (NSCLC)

Borghaei, H. ; Mehra, R. ; Millenson, M. M. ; Tuttle, H. ; Ruth, K. ; Magdalinski, A. J. ; Mintzer, D. M. ; Lee, J. ; Stevenson, J. ; Langer, C. J.

Texto completo disponível

A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)

Skaff, Z. G. ; Hageboutros, A. ; Krieger, K. ; Coakley, S. ; Somer, R. ; Stevenson, J.

Texto completo disponível

Improving breast cancer screening for indigent minorities: A county hospital cancer center's experience

O'Brien, T. E. ; Peacock, A. ; Stevenson, J. T.

Sem texto completo

Predictive factors for symptomatic radiation pneumonitis in 293 consecutively treated non-small cell lung cancer (NSCLC) patients receiving definitive radiation therapy

Orisamolu, A. ; Xanthopoulos, E. ; Fernandes, A. ; Christodouleas, J. P. ; Apisarnthanarax, S. ; Mitra, N. ; Wan, F. ; Langer, C. J. ; Evans, T. L. ; Stevenson, J. ; Sterman, D. ; Vachani, A. ; Haas, A. R. ; Rengan, R.

Texto completo disponível